Source link : https://www.newshealth.biz/health-news/venetoclax-obinutuzumab-clls-new-power-duo/
Phase 3 study on previously untreated chronic lymphocytic leukemia showed sustained PFS with venetoclax-obinutuzumab. Medscape Medical News Source link : https://www.medscape.com/viewarticle/venetoclax-obinutuzumab-clls-new-power-duo-2024a1000ket?src=rss Author : Publish date : 2024-11-08 08:01:55 Copyright for syndicated content belongs to the linked Source.
Author : News Health
Publish date : 2024-11-08 08:01:55
Copyright for syndicated content belongs to the linked Source.
inHealth